Evidence map›Paper›PMID 27613715›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2016

Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic Cells.

Zhen Ren, Si Chen, Jie Zhang, Utkarsh Doshi, Albert P Li, Lei Guo

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Roles of X-box binding protein 1 in liver pathogenesis.Clinical and molecular hepatology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline.Toxicology in vitro : an international journal published in association with BIBRA · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. GlutathioneFrontiers in pharmacology · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Zhen RenDivision of Biochemical Toxicology, National Center for Toxicological Research, U.S. FDA, Jefferson, Arkansas.
Si ChenDivision of Biochemical Toxicology, National Center for Toxicological Research, U.S. FDA, Jefferson, Arkansas.
Jie ZhangDivision of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. FDA, Jefferson, Arkansas.
Utkarsh DoshiIn Vitro ADMET Laboratories LLC, Columbia, Maryland.
Albert P LiIn Vitro ADMET Laboratories LLC, Columbia, Maryland.
Lei GuoDivision of Biochemical Toxicology, National Center for Toxicological Research, U.S. FDA, Jefferson, Arkansas; Lei.Guo@fda.hhs.gov.
In Vitro Admet Laboratories (United States) · USNational Center for Toxicological Research · USUnited States Food and Drug Administration · US

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

Nefazodone, an antagonist for the 5-hydroxytryptanine receptor, has been used for the treatment of depression. Acute liver injury has been documented to be associated with the use of nefazodone; however, the mechanisms of nefazodone-induced liver toxicity are not well defined. In this report, using biochemical and molecular analyses, we characterized the molecular mechanisms underlying the hepatotoxicity of nefazodone. We found that nefazodone induced endoplasmic reticulum (ER) stress in HepG2 cells, as the expression of typical ER stress markers, including CHOP, ATF-4, and p-eIF2α, was significantly increased, and splicing of XBP1 was observed. Nefazodone-suppressed protein secretion was evaluated using a Gaussia luciferase reporter assay that measures ER stress. The ER stress inhibitors (4-phenylbutyrate and salubrinal) and knockdown of ATF-4 gene attenuated nefazodone-induced ER stress and cytotoxicity. Nefazodone activated the MAPK signaling pathway, as indicated by increased phosphorylation of JNK, ERK1/2, and p38. Inhibition of ERK1/2 reduced ER stress caused by nefazodone. Taken together, our findings suggest that ER stress contributes to nefazodone-induced toxicity in HepG2 cells and that the MAPK signaling pathway plays an important role in ER stress.

Indexed as

Activating Transcription Factor 4Antidepressive Agents, Second-GenerationCell DeathCytochrome P-450 CYP3ADose-Response Relationship, DrugEndoplasmic Reticulum StressEnzyme ActivationEukaryotic Initiation Factor-2HepatocytesHep G2 CellsHumansMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhosphorylationPiperazinesRNA InterferenceActivating Transcription Factor 4Antidepressive Agents, Second-GenerationATF4 protein, humanCYP3A4 protein, humanCytochrome P-450 CYP3ADDIT3 protein, humanEukaryotic Initiation Factor-2MAPK1 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3nefazodonePiperazinesTranscription Factor CHOPTriazolesX-Box Binding Protein 1XBP1 protein, humandrug-induced liver toxicityendoplasmic reticulum stress (ER stress)MAPK pathwaynefazodone.reporter gene assay

Identifiers

PMID27613715
PMCPMC5727583
OpenAlexW2517873531

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.